Literature DB >> 27086652

Functional characterization of a novel β-fructofuranosidase from Bifidobacterium longum subsp. infantis ATCC 15697 on structurally diverse fructans.

Á Ávila-Fernández1, E Cuevas-Juárez2, M E Rodríguez-Alegría2, C Olvera2, A López-Munguía2.   

Abstract

AIM: In this study, we describe the isolation of a gene encoding a novel β-fructofuranosidase from Bifidobacterium longum subsp. infantis ATCC 15697, and the characterization of the enzyme, the second one found in this strain, significantly different in primary sequence to the already reported bifidobacterial β-fructofuranosidases. METHODS AND
RESULTS: The gene, found through genome-mining was expressed in Escherichia coli C41(DE3). The recombinant enzyme (B.longum_l1) has a molecular weight of 75 kDa, with optimal activity at 50°C, pH 6·0-6·5, and a remarkable stability with a half-life of 75·5 h at 50°C. B.longum_l1 has a wide specificity for fructans, hydrolysing all substrates through an exo-type mechanism, including Oligofructose P95 (β2-1 fructooligosaccharides (FOS), DP 2-8), Raftilose Synergy 1(β2-1 FOS & inulin, DP 2-60), Raftiline HP (inulin, DP 2-60), bacterial inulin (3000 kDa) and levan (8·3 & 3500 kDa), Agave fructans (mixed fructans, DP 3-29) and levan-type FOS (β2-6 FOS, DP 2-8), with the highest relative activity and turnover number found for levan-type FOS. The apparent affinity of the enzyme for levan-type FOS and Oligofructose P95 was found to be 9·2 and 4·6 mmol l(-1) (Km ) with a specific activity of 908 and 725 μmol min(-1)  mg(-1) of protein (k2 ), respectively, more than twice the activity for sucrose.
CONCLUSION: B.longum_l1 is a wide substrate specificity enzyme, which may contribute to the competitiveness and persistence of this strain in the colon. SIGNIFICANCE AND IMPACT OF THE STUDY: The bifidobacterial β-fructofuranosidase activity was evaluated with a wide variety of substrates including noncommercial fructans, such as levan-type and mixed agave fructans. Its activity on these substrates certainly strengthens their commercial prebiotic character and contributes to the understanding of bifidobacteria stimulation by structurally diverse fructans.
© 2016 The Society for Applied Microbiology.

Entities:  

Keywords:  agave fructans; fructan; fructanase; fructooligosaccharides; prebiotic

Mesh:

Substances:

Year:  2016        PMID: 27086652     DOI: 10.1111/jam.13154

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  5 in total

1.  Biosynthesis and prebiotic activity of a linear levan from a new Paenibacillus isolate.

Authors:  Rui Cheng; Long Cheng; Yang Zhao; Lei Wang; Shiming Wang; Jianfa Zhang
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-06       Impact factor: 4.813

Review 2.  Potential applications of recombinant bifidobacterial proteins in the food industry, biomedicine, process innovation and glycobiology.

Authors:  José A Morales-Contreras; Jessica E Rodríguez-Pérez; Carlos A Álvarez-González; Mirian C Martínez-López; Isela E Juárez-Rojop; Ángela Ávila-Fernández
Journal:  Food Sci Biotechnol       Date:  2021-08-03       Impact factor: 3.231

3.  Gene-Phenotype Associations Involving Human-Residential Bifidobacteria (HRB) Reveal Significant Species- and Strain-Specificity in Carbohydrate Catabolism.

Authors:  Shijie Liu; Zhifeng Fang; Hongchao Wang; Qixiao Zhai; Feng Hang; Jianxin Zhao; Hao Zhang; Wenwei Lu; Wei Chen
Journal:  Microorganisms       Date:  2021-04-21

4.  A Highly Active Endo-Levanase BT1760 of a Dominant Mammalian Gut Commensal Bacteroides thetaiotaomicron Cleaves Not Only Various Bacterial Levans, but Also Levan of Timothy Grass.

Authors:  Karin Mardo; Triinu Visnapuu; Heiki Vija; Anneli Aasamets; Katrin Viigand; Tiina Alamäe
Journal:  PLoS One       Date:  2017-01-19       Impact factor: 3.240

5.  Bifidogenic and butyrogenic effects of young barely leaf extract in an in vitro human colonic microbiota model.

Authors:  Daisuke Sasaki; Kengo Sasaki; Yasushi Kadowaki; Yasuyuki Aotsuka; Akihiko Kondo
Journal:  AMB Express       Date:  2019-11-13       Impact factor: 3.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.